References
- Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow- up study. Am J Cardiol. 1982;49:1758-66 https://doi.org/10.1016/0002-9149(82)90256-9
- Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85
- Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9
- Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315: 341-7 https://doi.org/10.1056/NEJM198608073150601
- Satou GM, Giamelli J, Gewitz MH. Kawasaki disease: diagnosis, management, and long-term implications. Cardiol Rev 2007;15:163-9 https://doi.org/10.1097/CRD.0b013e31802ea93f
- Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80
- Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178-222
- Rowley AH, Shulman ST. Kawasaki syndrome. Clin Microbiol Rev 1998;11:405-14
- Hong YM. Worldwide review of genetic studies in Kawasaki disease. J Korean Pediatr Cardiol Soc 2007;11:112-5 https://doi.org/10.3339/jkspn.2007.11.1.112
- Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, et al. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 2001;104:860-3 https://doi.org/10.1161/hc3301.095286
- Senzaki H, Kobayashi T, Nagasaka H, Nakano H, Kyo S, Yokote Y, et al. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy. Pediatr Res 2003;53:983-8 https://doi.org/10.1203/01.PDR.0000061566.63383.F4
- Shim YH, Kim HS, Sohn S, Hong YM. Insertion/deletion polymorphism of angiotensin converting enzyme gene in Kawasaki disease. J Korean Med Sci 2006;21:208-11 https://doi.org/10.3346/jkms.2006.21.2.208
- Quasney MW, Bronstein DE, Cantor RM, Zhang Q, Stroupe C, Shike H, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr Res 2001;49:686-90 https://doi.org/10.1203/00006450-200105000-00013
- Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 2004;56:953-9 https://doi.org/10.1203/01.PDR.0000145280.26284.B9
- Grossman MH, Emanuel BS, Budarf ML. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1 q11.2. Genomics 1992;12:822-5 https://doi.org/10.1016/0888-7543(92)90316-K
- Winqvist R, Lundstrom K, Salminen M, Laatikainen M, Ulmanen I. The human catechol-O-methyltransferase (COMT) gene maps to band q11.2 of chromosome 22 and shows a frequent RFLP with BgII. Cytogenet Cell Genet 1992;59:253-7 https://doi.org/10.1159/000133262
- Axelrod J, Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 1958;233:702-5
- Guldberg HC, Marsden CA. Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev 1975;27:135-206
- Ruiz-Sanz JI, Aurrekoetxea I, Ruiz del Agua A, Ruiz-Larrea MB. Detection of catechol-O-methyltransferase Val158Met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR. Mol Cell Probes 2007; 21:202-7 https://doi.org/10.1016/j.mcp.2006.12.001
- Hosk L. Role of the COMT gene Val158Met polymorphism in mental disorders: a review. Eur Psychiatry 2007;22:276-81 https://doi.org/10.1016/j.eurpsy.2007.02.002
- Zhu BT. Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab 2002;3:321-49 https://doi.org/10.2174/1389200023337586
- Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996;6:243-50 https://doi.org/10.1097/00008571-199606000-00007
- Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Meln K, Julkunen I, et al. Kinetics of human soluble and membrane- bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme Biochemistry 1995;34:4202-10 https://doi.org/10.1021/bi00013a008
- McLeod HL, Fang L, Luo X, Scott EP, Evans WE. Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans. J Pharmacol Exp Ther 1994;270:26-9
- Yoon KS, Yim DS, Jun G, Chung HH, Kim HM, Jang IJ, et al. Distribution of catechol O-methyltransferase genotypes in a healthy Korean population. J Korean Soc Clin Pharmacol 2000;8:196-201
- Hagen K, Pettersen E, Stovner LJ, Skorpen F, Holmen J, Zwart JA. High systolic blood pressure is associated with Val/Val genotype in the catechol-o-methyltransferase gene. The Nord-Trndelag Health Study (HUNT). Am J Hypertens 2007;20:21-6
- Voutilainen S, Tuomainen TP, Korhonen M, Mursu J, Virtanen JK, Happonen P, et al. Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: the kuopio ischaemic heart disease risk factor study. PLoS ONE 2007;2:e181 https://doi.org/10.1371/journal.pone.0000181
- Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, 1984
- Sol X, Guin E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006;22:1928-9 https://doi.org/10.1093/bioinformatics/btl268
- Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, Nagai M, et al. Kawasaki disease in families. Pediatrics 1989;84:666-9
- Bertocci B, Miggiano V, Da Prada M, Dembic Z, Lahm HW, Malherbe P. Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. Proc Natl Acad Sci U S A 1991;88:1416-20 https://doi.org/10.1073/pnas.88.4.1416
- Lundstrm K, Salminen M, Jalanko A, Savolainen R, Ulmanen I. Cloning and characterization of human placental catechol- O-methyltransferase cDNA. DNA Cell Biol 1991;10:181-9 https://doi.org/10.1089/dna.1991.10.181
- Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996;36:203-32 https://doi.org/10.1146/annurev.pa.36.040196.001223
- Eriksson AL, Skrtic S, Niklason A, Hultn LM, Wiklund O, Hedner T, et al. Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population. Eur Heart J 2004;25:386-91 https://doi.org/10.1016/j.ehj.2003.12.026
- Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015-22 https://doi.org/10.1001/jama.288.16.2015
- Nygrd O, Vollset SE, Refsum H, Brattstrm L, Ueland PM. Total homocysteine and cardiovascular disease. J Intern Med 1999;246:425-54 https://doi.org/10.1046/j.1365-2796.1999.00512.x